Literature DB >> 6340904

Clinical pharmacokinetics of metronidazole.

E D Ralph.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6340904     DOI： 10.2165/00003088-198308010-00003

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  73 in total

1.  Penetration of the blood brain barrier by metronidazole and tinidazole.

Authors:  A M Jokipii; V V Myllylä; E Hokkanen; L Jokipii
Journal:  J Antimicrob Chemother       Date:  1977-05       Impact factor: 5.790

2.  Letter: Treatment of a brain abscess due to Bacteroides fragilis with metronidazole.

Authors:  R H George; A J Bint
Journal:  J Antimicrob Chemother       Date:  1976-03       Impact factor: 5.790

3.  Anaerobic meningitis and bacteremia caused by Fusobacterium species.

Authors:  L R O'Grady; E D Ralph
Journal:  Am J Dis Child       Date:  1976-08

4.  The stereoselective interaction of warfarin and metronidazole in man.

Authors:  R A O'Reilly
Journal:  N Engl J Med       Date:  1976-08-12       Impact factor: 91.245

5.  An evaluation of metronidazole in the prophylaxis of anaerobic infections in obstetrical patients.

Authors: 
Journal:  J Antimicrob Chemother       Date:  1978-09       Impact factor: 5.790

6.  [Metronidazole-spiramycin combination. In situ concentrations and synergism compared with the minimal inhibitory concentration of the buccal flora].

Authors:  J Laufer; H Mignon; D Videau
Journal:  Rev Stomatol Chir Maxillofac       Date:  1974 Jul-Aug

7.  Pseudomembranous colitis after treatment with metronidazole.

Authors:  G Thomson; A H Clark; K Hare; W G Spilg
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-14

8.  Serum metronidazole levels following rectal administration.

Authors:  I F Lane; R W Pulvertaft; W G Hewitt
Journal:  J Antimicrob Chemother       Date:  1981-11       Impact factor: 5.790

Review 9.  Pathophysiological and disease-induced changes in drug distribution volume: pharmacokinetic implications.

Authors:  U Klotz
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

10.  Susceptibility of anaerobic bacteria to 23 antimicrobial agents.

Authors:  V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191
View more
  28 in total

1.  Anti-anaerobic antimicrobial agents: cefoxitin, cefotetan, clindamycin, and metronidazole.

Authors:  J A Bosso; R A Prince
Journal:  Tex Heart Inst J       Date:  1990

Review 2.  Pharmacokinetics of rectal drug administration, Part II. Clinical applications of peripherally acting drugs, and conclusions.

Authors:  E J van Hoogdalem; A G de Boer; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

3.  The effects of an investigational antimalarial agent, NIPRD-AM1 on the single dose pharmacokinetics of metronidazole in healthy human volunteers.

Authors:  Obiageri O Obodozie; Benjamin U Ebeshi; Kudirat B Mustapha; Rukaiyatu A Kirim; Margaret Ekpenyong; Uford S Inyang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2010-10-12       Impact factor: 2.441

Review 4.  Treatment failure in Trichomonas vaginalis vaginitis.

Authors:  W H Lumsden; D H Robertson; R Heyworth; C Harrison
Journal:  Genitourin Med       Date:  1988-08

Review 5.  Guide to drug dosage in renal failure.

Authors:  W M Bennett
Journal:  Clin Pharmacokinet       Date:  1988-11       Impact factor: 6.447

Review 6.  Pharmacokinetic considerations in the eradication of Helicobacter pylori.

Authors:  U Klotz
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

7.  Effects of food and formulation on the relative bioavailability of bismuth biskalcitrate, metronidazole, and tetracycline given for Helicobacter pylori eradication.

Authors:  Jean Spénard; Christian Aumais; Julie Massicotte; Jean-Sébastien Brunet; Claude Tremblay; Michael Grace; Marc Lefebvre
Journal:  Br J Clin Pharmacol       Date:  2005-10       Impact factor: 4.335

8.  Successful antimicrobial therapy of hepatic, intra-abdominal and intrapelvic abscesses.

Authors:  E D Ralph
Journal:  Can Med Assoc J       Date:  1984-09-15       Impact factor: 8.262

9.  Pharmacokinetics and tissue penetration of a single dose of ornidazole (1,000 milligrams intravenously) for antibiotic prophylaxis in colorectal surgery.

Authors:  C Martin; B Bruguerolle; M N Mallet; M Condomines; B Sastre; F Gouin
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

10.  Plasma metronidazole concentrations after single and repeated vaginal pessary administration.

Authors:  I G Salas-Herrera; M Lawson; A Johnston; P Turner; D M Gott; M J Dennis
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.